Tag Archives: IAS

Politicians and researchers discuss how to build political will to tackle TB/HIV at Aids conference

Left to right: Jirair Ratevosian, Cathy Jamieson MP, Dr Gavin Churchyard, Dr Richard Horton, Pamela Nash MP

On Tuesday 24th July at the International Aids Society Conference in Washington DC, USA, the APPG on Global Tuberculosis hosted the workshop  ‘Politics of Persuasion:  Empowering and Engaging Elected Representatives to Tackle TB/HIV through Research’ . The session was facilitated by Dr Richard Horton, Editor-in-chief of the Lancet, the world’s leading general medical journal on infectious diseases.

An audience of over 200 heard from guest speakers including Cathy Jamieson MP, member of the APPG on Global Tuberculosis, Pamela Nash MP, chair of the APPG on HIV/AIDS, Jirair Ratevosian, Legislative Director of the Hon Barbara Lee – co-founder of HIV/AIDS Caucus in House of Representatives, US Congress, Gavin Churchyard, CEO of the Arum institute and Jennifer Woolly, Director of Advocacy at Aeras.  The panellists discussed the importance of gaining a clear understanding of how researchers can engage with parliamentarians using scientific evidence to build political support and help drive policy change at the national, regional and international level.

The session highlighted the importance of advocacy as an essential communication tool for both parliamentarians and at the community level to raise awareness of latest developments in research and better understanding their full potential and implications for combating TB and HIV. Panellists discussed and demonstrated through their presentations how researchers, advocates and parliamentarians can work in better synergy with each to address these twinned global epidemics.

Dr Richard Horton

In his opening remarks Dr Horton made a  poignant statement:

“why don’t we take TB more seriously when talking about HIV?  It is the leading killer of people living with HIV, accounting for 1 in 4 deaths, yet it does not get the attention the suffering and loss of life it causes warrants”.

Dr Horton pointed to an article in the Lancet published in 2010 called ‘The HIV-associated tuberculosis epidemic—when will we act?’, which highlighted that despite policies, strategies, and guidelines, the epidemic of HIV-associated tuberculosis continues to rage.  Dr Horton stressed how important engagement with policy makers was to ensure appropriate action was taken to address HIV-TB co-infection.

Continue reading

Whoopi Goldberg calls on the world to do more to tackle TB-HIV co-infection

Last week, to mark the International Aid’s Society Conference, UNICEF Goodwill Ambassador Whoopi Goldberg posted a message on the Aids 2012 Conference Blog about TB-HIV co-infection. You can read Whoopi’s message in full here.

Whoopi GoldbergTB, or tuberculosis, is the biggest killer of people living with HIV. TB is an infectious disease which travels through spores in the air and is most likely to affect those with a weakened immune system, hence the high prevalence of the disease in those living with HIV.

However, TB is curable and preventable but it’s an often neglected disease which can be difficult to diagnose.

Whoopi explains in her blog how we need to pay more attention to the dual epidemic of TB-HIV in order to properly tackle both diseases and save millions of lives:

“I have heard a lot about the tragedy of AIDS orphans – but not enough about TB orphans. In 2009 there were some 10 million children in the world who had been orphaned by the death of a parent because of TB. TB is most typically a “family” problem. The vast majority of kids who become ill with TB catch it from a close family member before their TB has been diagnosed or treatment has begun. When you realize that, it’s easy to see that you can’t protect children against TB without addressing it within the family and wider community.

“What we need to do now is scale up methods that are already available. In countries heavily affected by HIV and TB, everyone should be offered testing for both diseases. That is not happening in most places now. Any person living with HIV who is diagnosed with TB needs prompt, life-saving TB treatment. If they don’t have TB, they should get life-saving preventive treatment with the drug isoniazid, so they won’t get TB. Needless to say ART should be started early – which also helps prevent TB.

“We also need programmes focused on maternal and child health to start paying attention to the risk of TB. What better place to start the integration of TB and HIV care for women and children than at the same clinics where they receive family planning services, prenatal care, immunizations and other services?

“By following these simple steps, millions of lives could be saved. But we could achieve even more with simpler diagnostic tests, more child-friendly drugs and a new vaccine. Research into these tools must be increased fast.

“The theme of AIDS 2012 is ‘Turning the Tide Together’. I truly hope everyone attending the conference—or reading this blog post – will recognize that to end AIDS we must join together to tackle TB and HIV as one disease. We must act now – for the sake of children and their families everywhere.”

There is a phrase we often in our advocacy work on TB: ‘TB anywhere is TB everywhere’. With an infectious disease such as TB, it’s crucial to ensure that quick, accurate and easy diagnosis is available to everyone and that once diagnosed, people have access to prompt and effective treatment.

RESULTS UK, as a partner of the ACTION Project, will continue to advocate for better diagnosis, treatment and recognition of TB and TB-HIV co-infection until families are no longer torn apart by the devastating disease that is tuberculosis.

The race is ON to stop HIV-AIDS suffering

Exert taken from Kolleen Bouchane’s blog, originally published on 21/07/2012 by Huffington Post.

I was still using colouring books when the first HIV/AIDS activists hit the streets. I knew about Ryan White and the discrimination in the U.S. from misinformation, fear and prejudice, but I had no idea then of the devastation AIDS would cause around the world; the lives it would take, the orphans it would create, the communities it would crush.

I also didn’t know how much I would learn from HIV and AIDS, and from people who live with it. Over the years I’ve had the privilege of meeting and learning from many people who have fought HIV in their own bodies, in their families and in their communities. Many of these people have taken their fight to the streets and to the highest levels of government in their own countries and around the world, creating everything from local support groups, to the revolutionary Global Fund to Fight AIDS, Tuberculosis and Malaria.

On July 24, ACTION will join other activists who will march in the streets of Washington, DC and deliver a call to action. At the top of these demands is a call that the President’s Emergency Plan for AIDS Relief (PEPFAR) reach 6 million people with ART by 2013 and that a plan is advanced that reaches 15 million people globally with ART by 2015.

Ending the suffering from AIDS IS possible in our lifetime. We need only look to the investment in and subsequent development of life-saving treatments and drugs that followed it. But the truth remains that millions will still die from AIDS and other related diseases, like tuberculosis, which kills one in four people living with HIV. They will die not only because they lack the necessary testing and treatment, but because they are being denied access to basic health services.

Last year, the Global Fund to Fight AIDS, Tuberculosis and Malaria was forced to cancel its 11th round of funding, highlighting how quickly progress can stall in the current economic climate. If we don’t act now to stop further cut-backs and compromises, the years of hard work and improvement we have seen in AIDS/HIV treatment will be irrevocably reversed.

This week, thousands will come to the International Aids Conference in DC to call on world leaders to do more. You can show your support by following the event and speaking out for the continued commitment of donor countries to the Global Fund.

Together we can win the race to end AIDS/HIV and TB suffering worldwide.

Saving lives by speaking out.

This blog was written by Kolleen Bouchane, Director of ACTION – a global partnership of advocacy organizations working to influence policy and mobilize resources to fight diseases of poverty and improve access to health services. ACTION’s current focus issues are tuberculosis (TB) — the leading killer of people with HIV/AIDS — and increasing equitable access to childhood vaccines.

UK staff leave for RESULTS International Conference

Aaron Oxley, ED of RESULTS UK, with John Mathai of Global Health Advocates India and a RESULTS US grassroots volunteer at the IC in 2011

Over the next couple of days, staff from all of the RESULTS affiliate countries, including the UK, will be heading to Washington D.C for the RESULTS International Conference. The annual conference brings together staff and grassroots volunteers from all of the RESULTS partner countries: US, UK, Canada, Mexico, Australia and Japan.

The conference features a wide range of top speakers, including Economist Jeff Sachs and Raj Shah, head of USAid.

Also during next week is the International AIDS Society Conference, the biggest gathering of AIDS activists and policy makers in the world, being held in the US for the first time since they lifted the entry ban on HIV+ people. Barack Obama and George W. Bush are due to open the conference on Sunday night. Members of the ACTION project and staff from the APPG-TB will be attending the conference to advocate on TB/HIV co-infection.

The next 10 days will certainly be busy but they should also be incredibly important for the future of RESULTS and AIDS advocacy around the world.

RESULTS UK meets with international Parliamentarians at the IAS

During this year’s International AIDS Conference in Vienna, RESULTS UK, in partnership with the All-Party Parliamentary Group on HIV and AIDS, organised a round table discussion with Parliamentarians and NGOs from around the world to discuss how to maximise and leverage the powerful role that Parliamentarians play across the world in the fight against HIV/AIDS and TB. Continue reading